- Home
- ACRE vs CLPT Comparison
ACRE vs CLPT Comparison
Compare ACRE & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- CLPT
- Stock Information
- Founded
- ACRE 2011
- CLPT 1998
- Country
- ACRE United States
- CLPT United States
- Employees
- ACRE N/A
- CLPT N/A
- Industry
- ACRE Real Estate Investment Trusts
- CLPT Medical/Dental Instruments
- Sector
- ACRE Real Estate
- CLPT Health Care
- Exchange
- ACRE Nasdaq
- CLPT Nasdaq
- Market Cap
- ACRE 351.6M
- CLPT 355.7M
- IPO Year
- ACRE 2012
- CLPT N/A
- Fundamental
- Price
- ACRE $7.30
- CLPT $11.75
- Analyst Decision
- ACRE Hold
- CLPT Strong Buy
- Analyst Count
- ACRE 7
- CLPT 2
- Target Price
- ACRE $7.10
- CLPT $12.00
- AVG Volume (30 Days)
- ACRE 442.9K
- CLPT 237.3K
- Earning Date
- ACRE 11-07-2024
- CLPT 11-07-2024
- Dividend Yield
- ACRE 13.86%
- CLPT N/A
- EPS Growth
- ACRE N/A
- CLPT N/A
- EPS
- ACRE N/A
- CLPT N/A
- Revenue
- ACRE $39,423,000.00
- CLPT $28,069,000.00
- Revenue This Year
- ACRE N/A
- CLPT $33.39
- Revenue Next Year
- ACRE $0.48
- CLPT $24.44
- P/E Ratio
- ACRE N/A
- CLPT N/A
- Revenue Growth
- ACRE N/A
- CLPT 29.33
- 52 Week Low
- ACRE $6.25
- CLPT $4.05
- 52 Week High
- ACRE $11.24
- CLPT $14.13
- Technical
- Relative Strength Index (RSI)
- ACRE 66.58
- CLPT 41.22
- Support Level
- ACRE $6.25
- CLPT $12.39
- Resistance Level
- ACRE $6.53
- CLPT $13.86
- Average True Range (ATR)
- ACRE 0.20
- CLPT 0.87
- MACD
- ACRE 0.06
- CLPT -0.10
- Stochastic Oscillator
- ACRE 85.71
- CLPT 33.57
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.